Two Years Into His Neuralink Implant, the First Patient Is Playing Chess With His Mind
Dr. Dereck Mush, MD, MBA
Precision Neuroscience
Designing high-density cortical implants for minimally invasive brain-computer interface solutions.
What they do
The company produces a high-density, ultra-thin microelectrode array that sits on the surface of the brain. Designed for temporary or permanent use, the device maps neural activity to help clinicians and patients communicate without damaging brain tissue.
The record
- Vertical
- Neurotech
- Sub-segment
- Brain computer interface
- Product type
- Device
- Stage
- Series B
- Headquarters
- New York, USA
- Region
- North America
- Founded
- 2021
- Total funding
- $141M raised
Notable investors: Forepoint Capital Partners, Mubadala Capital, Draper Associates.
Also in Neurotech
Related on The Signal
Dr. Dereck Mush, MD, MBA
Brain Computer Interfaces Enter Pivotal Trials: What Has to Go Right Before the First FDA Approval
Dr. Dereck Mush, MD, MBA
Next-Gen Neurotechnologies: Graphene Electrodes and Magnetic Surgical Robotics in Deep Brain Neuromodulation
Dr. Dereck Mush, MD, MBA
Overcoming the Solvent Front: How Jideytro Validates Nuvalent's Precision Oncology Playbook
Dr. Dereck Mush, MD, MBA